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A B S T R A C T
Superoxide dismutase 3 (SOD3) is an extracellular enzyme with the capacity to modulate extracellular redox
conditions by catalyzing the dismutation of superoxide to hydrogen peroxide. In addition to synthesis and re-
lease of this extracellular protein via the secretory pathway, several studies have shown that the protein also
localizes to intracellular compartments in neutrophils and macrophages. Here we show that human macrophages
release SOD3 from an intracellular compartment within 30min following LPS stimulation. This release acutely
increases the level of SOD3 on the cell surface as well as in the extracellular environment. Generation of the
intracellular compartment in macrophages is supported by endocytosis of extracellular SOD3 via the LDL re-
ceptor-related protein 1 (LRP1). Using bone marrow-derived macrophages established from wild-type and
SOD3−/− mice, we further show that the pro-inﬂammatory proﬁle established in LPS-stimulated cells is altered
in the absence of SOD3, suggesting that the active release of this protein aﬀects the inﬂammatory response. The
internalization and acute release from stimulated macrophages indicates that SOD3 not only functions as a
passive antioxidant in the extracellular environment, but also plays an active role in modulating redox signaling
to support biological responses.
1. Introduction
The enzymatic activity of extracellular superoxide dismutase (EC-
SOD or SOD3)1 supports the dismutation of superoxide to hydrogen
peroxide. In addition, the protein holds the capacity to bind cell surface
proteoglycans and constituents of the extracellular matrix via a posi-
tively charged C-terminal region (ECM-binding region) [1]. Based on
these properties, SOD3 has been described as an antioxidant im-
mobilized in the extracellular space, serving to protect cells and bio-
molecules against superoxide-induced damage [2–6] as well as pro-
tecting the bioactivity of nitric oxide by inhibiting the diﬀusion limited
reaction between NO and superoxide [7–9]. Interestingly, in the ab-
sence of exogenous oxidative stress, mice subjected to conditional ta-
moxifen-induced SOD3 KO developed severe lung injury characterized
by inﬂammatory cell inﬁltration and presented a signiﬁcant increase in
mortality [10]. This study suggests that SOD3 not only serves to protect
biomolecules against superoxide-induced damage under conditions of
oxidative stress, but also partakes in the control of the inﬂammatory
response in basal conditions. The association between SOD3 and the
inﬂammatory response has also been established in several in vivo
models using SOD3−/− mice or mice overexpressing SOD3 establishing
that the protein acts as an anti-inﬂammatory mediator [11–17].
Moreover, studies have suggested a role of SOD3 in regulating tran-
scription factor activity [18,19] as well as aﬀecting signal transduction
by regulating the activity of protein tyrosine phosphatases [20]. It is
thus evident that SOD3 is not only a passive antioxidant providing
extracellular protection against superoxide-mediated damage but also
participates actively in regulating diverse biological functions.
Transcription of the SOD3 gene is epigenetically regulated by both
methylation of the promotor region as well as by histone acetylation/
deacetylation controlling gene accessibility [21–25]. These elements
are likely to explain the ﬁnding that SOD3 protein can be detected in
only a limited amount of cell types including pulmonary ﬁbroblasts and
epithelial cells as well as vascular smooth muscle cells [26–30]. Indeed,
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the lack of SOD3 expression in human pulmonary artery endothelial
cells has been shown to rely on epigenetic regulation, as the expression
could be induced by demethylation of the promotor region as well as
modulation of histone acetylation [22,31]. Moreover, the expression
can be upregulated by cytokines including IFNγ and IL-4 whereas TNFα
downregulate the expression [22,32,33]. The transcriptional regulation
of SOD3 is an adaptive response that may develop over several days
[32], and cannot be mobilized for an acute response.
Several studies have shown that SOD3 is present in inﬂammatory
cells including macrophages and neutrophils [34–37]. We have recently
shown that SOD3 is only released from macrophages and neutrophils
upon cellular stimulation with LPS and fMLF, respectively [36,37].
Moreover, LPS was also found to induce secretion of SOD3 from iso-
lated astrocytes [38]. Interestingly, the secretion was not reﬂected by
an increase in the level of SOD3 mRNA, suggesting that the release was
established from a preformed population. High resolution analyses of
isolated neutrophils and macrophages by electron microscopy show
that SOD3 is present in intracellular vesicles [36,39]. Since SOD3 is
synthesized in the secretory pathway and secreted as an extracellular
protein, this ﬁnding indicates that SOD3 is internalized from the ex-
tracellular space to be stored in an intracellular compartment and only
released upon stimulation. In concert, our data suggest that the sti-
mulated release of SOD3 represents an acute response providing SOD
activity to the extracellular environment.
To understand the control of SOD3 activity in the extracellular
space, we have characterized the cellular distribution of SOD3 in
macrophages in detail. We show that SOD3 is released within 30min of
macrophage stimulation, correlating with the kinetics of TNFα release
[40]. Moreover, we show that SOD3 is mobilized from pre-formed in-
tracellular vesicles likely established by receptor-mediated endocytosis
supported by the interaction between LDL receptor-related protein 1
(LRP1) and SOD3 [41]. Analysis of the functional impact of this sti-
mulated release was evaluated using macrophages isolated from wild-
type and SOD3−/− mice, and showed that the absence of SOD3 sig-
niﬁcantly increased the level of secreted pro-inﬂammatory cytokines
and chemokines, including CXCL2 and sICAM-1. Collectively, our data
show that the level of SOD3 activity in the ECM is regulated by acute
cellular release and underscores that this dynamic distribution will
need to be considered, when studying redox conditions at both oxida-
tive eustress and distress.
2. Materials and methods
Human serum, M-CSF, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N'-
tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM), acutase,
and ovalbumin was from Sigma. Heparin (5000 U/ml) was obtained
from Leo Pharma, Denmark and complete protease inhibitor tablets was
from Roche.
Proteins: Recombinant wild-type SOD3 and SOD3 containing a C-
terminal c-Myc tag (SOD3-cMyc) was produced as previously described
[42]. For the generation of the SOD3-cMyc expression plasmid, we used
the forward primer (5′-TATACAGCTAGCATGCTGGCGCTACTGTGT
TCC-3′) and a reverse primer encompassing the cMyc tag (underlined) (
5′-TATGAATTCTCACAGATCCTCTTCTGAGATGAGTTTTTGTTCGGCGG
CCTTGCACTCGCTCTC-3′) and cloned the product into the pIRES
vector. The sequence of the obtained plasmid was veriﬁed by sequen-
cing. mAb 5G8D4 and 7F6D9 anti-human SOD3 (GenScript) and rabbit
anti SOD3 antisera (Davids Biotechnologie) were developed using re-
combinant human SOD3 as antigen and antibodies recovered by using
protein G-Sepharose. Recombinant human and murine IFNγ was ob-
tained from Invitrogen. Ovalbumin was from Sigma. Human receptor-
associated protein (RAP) was obtained from ENZO life sciences (BML-
SE552). HRP-conjugated goat anti-rabbit Ig was from DAKO. Flow cy-
tometric analyses were performed using PE-conjugated anti-CD14 (B&D
Biosciences), APC-conjugated anti-CD4 (B&D Biosciences) or APC-con-
jugated mAb5G8D4 anti-SOD3.
2.1. Cell culture
Human monocytes were isolated from buﬀy coats using Ficoll-
paque™ PLUS (GE Healthcare). Brieﬂy, the buﬀy coat material was di-
luted in PBS (without Mg2+ and Ca2+) containing 2mM EDTA and the
diluted material layered on top of a Ficoll-paque™ PLUS cushion and
centrifuged for 30min at 1.000×g. The established layer of lympho-
cytes and monocytes was removed and subsequently washed twice in
PBS and seeded in 10 cm petri dishes in RPMI 1640 containing 2%
human serum, 100 U/ml penicillin and 100 μg/ml streptomycin
(hsRPMI). Monocytes were allowed to adhere for 3 h where after
medium was removed and cells wash twice with PBS before receiving
hsRPMI containing 20 ng/ml M-CSF. After overnight incubation, 50%
of the medium was exchanged for fresh medium, and the cells allowed
to diﬀerentiate into M0 macrophages and used after 7–10 days of dif-
ferentiation.
2.2. SDS-PAGE and western blotting
SDS-PAGE analysis was performed using uniform 10% poly-
acrylamide gels and the glycine/2-amino-2-methyl-1,3-propanediol-
HCl buﬀer system described previously [43]. Reducing conditions were
obtained by boiling samples in the presence of 0.5% (w/v) SDS and
50mM dithiothreitol prior to electrophoresis. For Western blotting,
separated proteins were electrophoretically transferred to a poly-
vinylidene diﬂuroride membrane for 1 h at 150mA in 10mM 3-(cy-
clohexylamino)-1-propane sulfonic acid (pH 11) containing 10% (v/v)
ethanol [44]. The membranes were blocked with 5% (w/v) skimmed
milk in 20mM Tris-HCl (pH 7.4), 137mM NaCl supplemented with
0.1% (v/v) Tween 20 (TBST) and SOD3 protein detected by using a
rabbit anti-SOD3 antiserum. Blots were developed by ECL using per-
oxidase-conjugated goat anti-rabbit Ig and data acquired using an Im-
ageQuant LAS 4000 instrument (GE Healthcare).
2.3. Enzyme-linked immunosorbent assays
The concentration of SOD3 in cell culture supernatants was de-
termined by a sandwich ELISA. Microtiter wells (MaxiSorb, Nunc) were
coated with a polyclonal rabbit IgG directed against SOD3 using 0.1 μg
in 100 μl 50mM carbonate/bicarbonate buﬀer, pH 9.6. The wells were
incubated over night at 4 °C, emptied and residual binding-sites blocked
for 1 h by the addition of 0.1% (w/v) BSA in TBS. Samples were diluted
in TBST and a standard curve generated using puriﬁed recombinant
SOD3. The wells were incubated over night at 4 °C, washed thrice in
TBST, and incubated with 100 μl mAb 7F6D9 anti-SOD3 in TBST using
a concentration of 1 μg/ml. Bound antibody was subsequently detected
by the addition of HRP-conjugated rabbit anti-mouse antibody and
wells developed by using the O-phenylenediamine dihydrochloride-
system following the manufacturer's instructions (Sigma). Color devel-
opment was assessed by absorption at 450 nm.
The detection of murine TNFα in the cell culture supernatant of
stimulated bone marrow-derived macrophages was determined by
using the DuoSet ELISA kit as described by the manufacturer (R&D
systems).
2.4. Immunoprecipitation
CNBr-activated Sepharose was derivatized with mAb 5G8D4 as
suggested by the manufacturer (GE Healthcare) at a concentration of
2mg Mab/ml resin. The equilibrated resin was incubated with cell
culture supernatants or cell lysates diluted in 10-fold in PBS and al-
lowed to bind over night at 4 °C with end-over-end mixing. The resin
was recovered by centrifugation, washed thrice in PBS, and bound
proteins eluted by boiling the resin in the presence of SDS-PAGE sample
buﬀer containing 0.5% SDS and 50mM dithiothreitol.
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2.5. RT-qPCR
Total RNA was isolated from LPS-stimulated HMDMs by using the
High Pure RNA Isolation Kit (Roche) and reverse transcription subse-
quently performed using the SuperScript One-Step RT-PCR kit
(Invitrogen). Primers used for analysis were; Sod3F, 5′-CTTCGCCTCT
GCTGAAGTCT-3′); Sod3R, 5′-GGGTGTTTCGGTACAAATGG-3′; GapdhF,
5′-GCACCGTCAAGGCTGAGAAC-3′; GapdhR, 5′-ATGGTGGTGAAGACG
CCAGT-3′. Relative quantitative real-time PCR used SYBR Green PCR
Master Mix kit (Applied Biosystems). After pre-ampliﬁcation (95 °C for
2min), the PCRs were ampliﬁed for 40 cycles (95 °C for 15 s and 60 °C
for 1min). Each mRNA expression was normalized against GAPDH
mRNA expression using the comparative cycle threshold method.
2.6. Release of SOD3 from human monocyte-derived macrophages
(HMDM)
To evaluate the secretion of SOD3 from macrophages, HMDMs were
seeded in 6 well plates (5×104 cells/cm2) and allowed to adhere
overnight. Subsequently, cells were washed in PBS, stimulated in 2ml
hsRPMI containing 100 ng/ml LPS and the cell culture supernatant re-
covered at the indicated time-points. To evaluate the involvement of
exocytosis, cells were washed in PBS and pre-incubated for 15min in
PBS containing the indicated concentrations of BAPTA-AM, which in-
hibits vesicular exocytosis by the chelation of intracellular calcium. The
secretion of SOD3 was subsequently stimulated by the addition of
100 ng/ml LPS for 1 h.
2.7. Cellular uptake of SOD3
Human macrophages were seeded in 6 well plates (5× 104 cells/
cm2) and pulsed with SOD3-cMyc (500 ng/ml) or ovalbumin (500 ng/
ml) in 2ml fcsRPMI for 90min. Cells were subsequently washed in PBS
containing 50 U/ml heparin and lysed at the indicated time points by
the addition of ice-cold 50mM Tris–HCl, 150mM NaCl, 2 mM EDTA,
1% Triton X-100, 20mM N-ethylmaleimide, pH 7.4, supplemented with
complete protease inhibitors (lysis buﬀer). Cellular uptake of SOD3-
cMyc was likewise evaluated in the presence of heparin or receptor
associated protein (RAP) as indicated.
2.8. Flow cytometry
Human monocyte-derived macrophages were stimulated by using
100 ng/ml LPS in hsRPMI for the indicated time points. Cells were re-
covered by using acutase, washed twice in hsRPMI and maintained in
hsRPMI at 106 cells/ml. To allow for antibody labelling, 0.5× 106 cells
(500 μl) were removed and incubated with PE-conjugated anti-CD14,
APC-conjugated anti-CD4 or APC-conjugated 5G8D4 anti-SOD3.
Moreover, we included an isotype control for 5G8D4 (APC-conjungated
IgG1) as a negative control. All incubations were performed at 23 °C and
in the dark. Flow cytometric analysis was performed using a LSR
Fortessa cell analyzer (B&D Biosciences) using a 640 nm laser to excite
APC (emitted light collected in a 670/30 band pass ﬁlter), and a 561 nm
laser to excite PE (emitted light collected in a 586/15 band pass ﬁlter).
More than 10,000 cells were counted for each sample. The obtained
data were processed using the FlowJo software (V.9.6.2, TreeStar Inc,
Ashland, OR).
2.9. Confocal microscopy
Human monocytes were puriﬁed as above, except that Ficoll-
paque™ PLUS separation was followed by CD11b-immunomagnetic
isolation according to recommendations of the manufacturer (Milteny).
Monocytes were cultured as above and diﬀerentiated for 7 days with M-
CSF (20 ng/ml) before use. To assess exocytosis and surface disposition
of SOD3, macrophages were stimulated with 100 ng/ml LPS for 1 h
before wash in ice-cold HBSS. Subsequently, 2 μg/ml anti-SOD3 mAb
7F6D9 was added together with 2 μg/ml Alexa633-conjugated cholera
toxin B-subunit (CTB) for 30min on ice to detect SOD3 on the surface,
before wash and Alexa488-conjugated secondary goat-anti mouse an-
tibodies. After a ﬁnal wash, cells were ﬁxed in paraformaldehyde for
observation. Immunoﬂuorescence was performed on paraformaldehyde
ﬁxed macrophages according to standard procedures using permeabi-
lization with 0.2% saponin. In some wells cells were allowed to en-
docytose DiI-conjugated Acetylated-LDL (AcLDL) and Alexa633-con-
jugated CTB for 2 h before ﬁxation. The following primary antibodies
were used: anti-SOD3 polyclonal rabbit antibodies ESC1 and ESC2, anti-
AP3δ mAb SA4 and anti-LAMP1 polyclonal mAb H4A3 (both Iowa
Hybridoma Gene Bank), followed by Alexa488-conjugated goat-anti
mouse antibodies or Alexa568-conjugated goat-anti mouse antibodies,
as speciﬁed. Cells were counter stained with Alexa633-conjugated
phalloidin to reveal cell shape. Slides were examined with a Zeiss LSM
510 confocal laser scanning microscope using a C-Apochromat 633, 1.2
water immersion objective (Carl Zeiss). Images were collected and
saved as a 1024×1024-pixel image at 8-bit resolution before import
into Adobe Photoshop (Adobe Systems) for compilation.
2.10. Mouse cytokine array analysis
Murine bone marrow-derived macrophages were established from
femurs and pelvises recovered from wild-type and SOD3−/− mice as
previously described [37]. Isolated and diﬀerentiated cells were seeded
in 6 well plates (0.5× 106 cells) and stimulated for 16 h by 10 ng/ml
murine IFNγ in RPMI supplemented with 10% FCS, 100 U/ml penicillin
and 100 μg/ml streptomycin. To stimulate SOD3 release, 100 ng/ml LPS
was added to the medium and cell culture supernatants (2 ml) were
removed after 16 h. Equal volumes of supernatants representing wild-
type or SOD3−/− mice were pooled and used to probe the Mouse cy-
tokine array panel A as described by the manufacturer (R&D Biosys-
tems). The intensities of the spots developed on the membranes were
determined by using the ImageJ software and relative intensity ad-
justed on basis of the 6 reference points. The normalized pixel intensity
of the individual cytokines was subsequently determined.
3. Results
3.1. The fast release of SOD3 from macrophages reﬂects protein secretion
We have previously shown that SOD3 is actively released from LPS-
stimulated murine bone marrow-derived macrophages [37]. To further
evaluate the dynamics of this release, we stimulated HMDMs with LPS
and collected cell culture supernatants at increasing time points. Ana-
lyses by Western blotting (Fig. 1A) and ELISA (Fig. 1B) show that SOD3
can be detected in the cell culture medium after 30min of stimulation
and that the released level continues to increase within 6 h. Corre-
spondingly, the level of SOD3 in the cell lysates decreased (Fig. 1A).
Determination of transcriptional level of SOD3 by quantitative RT-PCR
shows that the level of SOD3 mRNA is not signiﬁcantly aﬀected within
6 h, suggesting that release of SOD3 does not reﬂect increased tran-
scriptional activity (Fig. 1C). These data show that the SOD3 protein
released from macrophages is pre-formed and mobilized from a cellular
compartment. To support this conclusion, we pre-incubated macro-
phages with BAPTA-AM, which is cell permeable chelator capable of
inhibiting vesicular exocytosis by the chelation of intracellular calcium.
Analysis of cell culture supernatant collected from cells stimulated with
LPS clearly shows that the presence of BAPTA-AM inhibits the release of
SOD3, with complete inhibition observed by using 50 μM BAPTA-AM
(Fig. 2A and B). The inhibition of release was reﬂected by the retention
of SOD3 in the cell lysates, as evident by Western blot analysis
(Fig. 2A). In agreement with these results, we found by immuno-
ﬂuorescence analysis that macrophages contain an intracellular pool of
SOD3 in small vesicles (Fig. 2C). We addressed whether this pool of
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SOD3 could potentially be contained in so-called lysosome related or-
ganelles (LRO's), however we found little colocalization with lysosomal
marker LAMP1 or the lysosomally directed endocytic probe acetylated-
LDL (Ac-LDL), and neither did SOD3 staining overlap with AP3δ, which
has been implicated in sorting to LRO's. Endocytosed CTB, which
transits through endosomes and accumulates in the Golgi, neither
showed any appreciable colocalization with SOD3. In concert, these
data show that LPS stimulation of HMDMs mobilize intracellular SOD3-
containing vesicles supporting the release of the protein into the ex-
tracellular environment.
3.2. Cell surface-associated SOD3 is increased in LPS-stimulated
macrophages
Since the stimulation of HMDMs by LPS appears to mobilize in-
tracellular stores of SOD3, we investigated if vesicular exocytosis also
supported an increase of cell surface-associated SOD3 by ﬂow cyto-
metry. The diﬀerentiation of the cells was veriﬁed by using CD4 and
CD14 antibodies and viable and monodisperse HMDMs were gated
Fig. 1. SOD3 is released from a preformed pool. HMDMs were stimulated by the
addition of LPS and the supernatant collected at the indicated time points. The
supernatant and corresponding cell lysates were analyzed by (A) im-
munoprecipitation/Western blotting. As a control of immunoprecipitation, we
performed parallel analysis in the absence (−) or presence (+) of puriﬁed
recombinant SOD3. Additionally, the presence of SOD3 in the supernatant was
evaluated by ELISA (B). (C) The transcriptional level of SOD3 upon LPS sti-
mulation was evaluated by RT-qPCR and presented relatively to the level in the
absence of LPS (t= 0min). This analysis shows that the release of SOD3 from
macrophages is relative fast and does not reﬂect a transcriptional upregulation.
Error bars in panel B and C represents mean ± SD (n=3).
Fig. 2. LPS-stimulation mobilize SOD3-containing intracellular vesicles. (A)
HMDMs were pre-incubated with BAPTA-AM at the indicated concentrations
and SOD3 release subsequently stimulated by the addition of LPS (100 ng/ml).
Cell culture supernatants and lysates were analyzed for the presence of SOD3 by
immunoprecipitation and SDS-PAGE/Western blotting. Control for im-
munoprecipitation is indicated on the left. (B) The level of SOD3 in the cell
culture supernatant was likewise determined by using ELISA. (C)
Immunoﬂuorescence of unstimulated HDMDs shows an intracellular localiza-
tion of SOD3 in small vesicles, that does not overlap with localization of lyso-
somal markers AP3δ, LAMP1 or DiI-conjugated Ac-LDL. Images are re-
presentative of three separate experiments. These data show that SOD3 is
mobilized from stimulated macrophages by exocytosis of intracellular vesicles.
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using forward and side scatter channels (Fig. S1). The speciﬁcity of the
analysis conﬁrmed by staining of cells using an isotype control anti-
body, which showed no intensity above background (Fig. S1). To allow
for the analysis of surface-associated SOD3 only, cells were not per-
meabilized prior to the analysis. Analysis of stimulated cells showed
that the level of cell surface-associated SOD3 increased within the ﬁrst
hours of stimulation as evident by increasing median ﬂuorescent values
(Fig. 3). After 6 h of stimulation, the median value decreased, indicating
the level of surface-associated SOD3 is reduced following an initial
burst. Based on the> 10-fold increase of the median value between the
initial state (696) and at 4 h (10250), these data suggest that the level of
SOD3 on the cell surface is increased dramatically. To obtain a visual
correlate, HMDMs were stimulated with LPS and the localization of
SOD3 on the cell surface was detected by anti-SOD3 antibodies on
living cells for confocal microscopical analysis. LPS aﬀorded a clearly
increased complement of SOD3 on the cell surface (Fig. 3B). Moreover,
LPS-stimulation increased the association with lipid rafts (CTB) as
previously described [37]. In concert, LPS stimulation of HMDMs
markedly aﬀects the cellular distribution of SOD3 increasing the level
of both cell surface-associated as well as protein released into the ex-
tracellular environment.
3.3. Internalization and release of exogenous SOD3
Since SOD3 is an extracellular glycoprotein without any well-de-
ﬁned tags for cellular sorting prior to secretion, it is likely that the
establishment of intracellular vesicles is mediated by endocytosis of
secreted protein. Indeed, SOD3 has previously be reported to be inter-
nalized by endothelial cells and ﬁbroblasts [45–47], as well as by re-
ceptor-mediated endocytosis by hepatocytes [41]. Moreover, we have
recently shown that SOD3 is present in secretory vesicles of neutrophils,
which are established by endocytosis [36]. To evaluate endocytosis, we
incubated HMDMs in the presence of recombinant SOD3 encompassing
a C-terminal c-Myc tag (SOD3-cMyc) allowing us to distinguish between
endogenous and exogenous SOD3 by using an antibody directed against
the cMyc-tag. In parallel, we incubated cells with ovalbumin serving as
a marker of endocytosis and intracellular degradation. After a pulse of
90min, cells were washed in PBS containing heparin to remove cell
surface associated SOD3-cMyc and maintained in medium for the in-
dicated time points (Fig. 4). Analysis of cell culture lysates by Western
blotting shows that SOD3-cMyc is internalized and can be detected
within the macrophage after overnight incubation. Ovalbumin was also
internalized but could not be detected after 6 h, indicating that the
protein is degraded (Fig. 4). These data show that SOD3 is internalized
by macrophages and that a fraction of the protein is likely stored in an
intracellular compartment. To investigate if internalized SOD3-cMyc
could be released from this intracellular compartment, we pulsed
HMDMs with SOD3-cMyc, washed the cells in the presence of heparin
and stimulated them with LPS (Fig. 5). Correlating with data presented
in Fig. 1A, SOD3 could not be detected in the supernatant in the ab-
sence of LPS stimulation whereas the presence of LPS stimulated the
release, as evident by Western blotting using an anti-SOD3 antiserum
(Fig. 5, upper panel). In addition, we could also detect SOD3-cMyc
protein in the culture supernatant of LPS-stimulated cells pulsed with
SOD3-cMyc protein using both an SOD3-directed antiserum (upper
panel) as well as a speciﬁc anti-cMyc antibody (Fig. 5, lower panel).
These data show that SOD3 is internalized, stored, and subsequently
released upon LPS stimulation.
Fig. 3. Cell surface-associated SOD3 in increased upon stimulation. (A) The
level of cell surface-associated SOD3 on resting and LPS-stimulated HMDMs
was evaluated by using ﬂow cytometry. Stimulated cells were ﬁxed after the
indicated time points and surface associated SOD3 detected by using an APC-
conjugated mAb 5G8D4. Cells were gated to select live and monodisperse
HMDMs (Fig. S1). The analysis was repeated three times with cells obtained
from separate donors producing similar results. (B) Cell surface-associated
SOD3 was evaluated by confocal microscopy. Cell surface staining of SOD3 and
cholera toxin B-subunit (lipid rafts) on live HDMDs treated or not with LPS
shows a substantially increased localization of SOD3 to the surface of LPS-
treated cells. These analyses show that the level of cell surface-associated SOD3
is increased by LPS stimulation.
Fig. 4. SOD3 is internalized and stored intracellularly. (A) HMDMs were added
medium containing ovalbumin or cMyc-tagged SOD3 and incubated for 90min.
The medium was subsequently removed, the cells washed in the presence of
heparin (50 U/ml) and cells subsequently lysed at the indicated time points.
The recovered lysates were analyzed for the presence of ovalbumin and SOD3-
cMyc by SDS-PAGE/Western blotting. The analysis was performed three times.
This analysis shows that internalized SOD3-cMyc is maintained within the cell
whereas ovalbumin is degraded.
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3.4. SOD3 is internalized by receptor-mediated endocytosis
To investigate the basis of SOD3 uptake in human macrophages, we
incubated HMDMs with SOD3-cMyc in the presence of increasing
amounts of heparin to compete for cell surface binding of SOD3-cMyc
via the ECM-binding region. Analysis of cell lysates by Western blotting
shows that heparin dose-dependently inhibits the internalization of
SOD3-cMyc (Fig. 6A), suggesting that the interaction with cell surface
heparan sulfate proteoglycans is essential for cellular uptake. We have
previously shown that SOD3 interacts with the cell surface receptor
LRP1 (CD91) [41]. Since the binding to cell surface heparan sulfate
proteoglycans is important for the internalization of a number of LRP1
ligands, we investigated if LRP1 could support SOD3 internalization. To
investigate this, we used the receptor-associated protein (RAP), which
is a universal inhibitor of LRP1-ligand interactions [48]. Analysis of
lysates obtained from HMDMs incubated with SOD3-cMyc in the pre-
sence of increasing levels of RAP, showed that the internalization was
inhibited by RAP (Fig. 6B). Collectively, these data show that the in-
teraction between LRP1 and SOD3 mediated by heparan sulfate pro-
teoglycans supports the internalization of SOD3 in HMDMs.
3.5. Secretion of SOD3 aﬀects the macrophage cytokine response
One important eﬀector function of activated macrophages is the
secretion of cytokines. To evaluate if the temporal secretion of SOD3
from LPS-stimulated macrophages aﬀected the proﬁle of secreted cy-
tokines, we established bone marrow-derived macrophages (BMM)
from both wild-type and SOD3−/− mice and stimulated a pro-in-
ﬂammatory response by the addition of IFNγ and LPS. Analysis by
Western blotting showed that indeed SOD3 was quickly released from
BMMs isolated from wild-type animals (Fig. S2), with a kinetic proﬁle
comparable to that of HMDMs (Fig. 1A). As expected, no SOD3 was
released from BMMs established from SOD3−/− mice (Fig. S2). Su-
pernatants collected from BMMs representing wild-type or SOD3−/−
mice were pooled and used to probe a mouse cytokine array panel (Fig.
S3A). This analysis showed that the release of several cytokines were
signiﬁcantly increased in the absence of SOD3, including TNFα (Fig. 7).
To validate the ﬁndings obtained by the array, we analyzed the
collected supernatants by using a TNFα-speciﬁc ELISA. This analysis
conﬁrmed that indeed the level of this cytokine was signiﬁcantly ele-
vated in supernatants of BMMs derived from SOD3−/− mice (Fig. S3B).
Interestingly, in addition to TNFα upregulation, the chemokine CXCL2
(MIP2α) was also found to be signiﬁcantly upregulated in the absence
Fig. 5. Internalized SOD3 is released from stimulated HMDMs. Cells were
cultured in the absence or presence of SOD3-cMyc for 90min to allow for in-
ternalization. Cells were washed and added buﬀer or stimulated by the addition
of LPS for 1 h as indicated. Cell culture supernatants were collected and ana-
lyzed by immunoprecipitation and SDS-PAGE/Western blotting. Two separate
membranes were developed using an anti-SOD3 antiserum and Mab 9E10 anti-
cMyc. Puriﬁed SOD3 and SOD3-cMyc was included as controls on the left. This
analysis shows that internalized SOD3 is released from HMDMs upon LPS sti-
mulation.
Fig. 6. SOD3 is internalized by receptor-mediated endocytosis. (A) HMDMs
were incubated with SOD3-cMyc (500 ng/ml) in the presence of increasing
amounts of heparin as indicated for 90min. Cells were subsequently washed,
lysed and the recovered lysate analyzed by immunoprecipitation and SDS-
PAGE/Western blotting. The uptake of SOD3 was evaluated by using the mAb
9E10 anti-cMyc. (B) The involvement of LRP1 in internalization was evaluated
by incubating SOD3-cMyc in the presence of increasing molar ratios of RAP, an
inhibitor of LRP1-ligand interactions. The cells were incubated in 90min and
the lysates analyzed as in (A). The experiments were repeated three times with
similar results. This analysis shows that SOD3 is internalized into HMDMs via
LRP1 interaction.
Fig. 7. SOD3 modulates the pro-inﬂammatory cytokine proﬁle of LPS-stimu-
lated macrophages. Bone marrow-derived macrophages were established from
wild-type and KO mice and stimulated by IFNγ and LPS for 16 h. Cell culture
supernatants were collected and the pro-inﬂammatory cytokine proﬁle was
established by using the Mouse cytokine array panel A (R&D systems). Cell
culture supernatants were pooled from wild-type mice (n=3) or SOD3 KO
mice (n=3) and used to probe the membrane. The intensity of the developed
spots was evaluated as described by the manufacturer by using ImageJ software
and presented as corrected pixel intensity with error bars indicating
mean ± SD. Data were analyzed by Student's t-test and p < 0.05 indicated
(*).
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of SOD3, correlating well with the observation that overexpression of
SOD3 in mice signiﬁcantly reduce the level these two cytokines in a
model of LPS-induced pulmonary inﬂammation [11]. In conclusion, the
absence of SOD3 aﬀects the proﬁle of cytokines produced by isolated
macrophages and indicates that stimulus-induced release of SOD3 in-
deed aﬀects inﬂammatory response established by the macrophage.
This notion correlates well with the body of evidence showing that
SOD3 acts as an anti-inﬂammatory protein in a number of in vivo
models [11,12,14,16].
4. Discussion
By virtue of its enzymatic activity, SOD3 has the capacity to remove
superoxide generated in the extracellular space, and hence protect
constituents in this compartment against oxidative modiﬁcation and
degradation [2–6]. However, the activity of SOD3 can also be appre-
ciated as a source of H2O2 in the extracellular environment for potential
autocrine or paracrine redox signaling. As H2O2 plays a central role in
redox signaling, it is highly plausible that SOD3 indeed will aﬀect
redox-regulated processes and hence function as both an antioxidant as
well as a prooxidant in the extracellular space [49]. The impact of this
notion is becoming increasingly relevant, as it has been established that
H2O2 crosses biological membranes not only by passive diﬀusion, but
also by active transport supported by peroxiporins (aquaporins)
[50–52] and that this transport indeed impacts on cellular biology [53].
This implies that H2O2 generated in the extracellular space may aﬀect
the redox status of intracellular targets, and it is consequently essential
to understand how the activity of SOD3 in the extracellular space is
regulated.
We have previously shown that SOD3 is released into the extra-
cellular environment from LPS-stimulated macrophages [37]. Now we
show that this release is supported by the mobilization of an in-
tracellular compartment within 30min after stimulation. This fast re-
lease correlates with that observed for TNFα [40] and indicates that the
release of SOD3 is important in the early response of the macrophage.
The molecular basis of this release is not clear, as the protein collected
in the supernatant appears to be intact and hence withholds the ECM-
binding region (Fig. 1A) [37]. However, as BAPTA-AM inhibits this
process (Fig. 2) it is evident that exocytosis is essential. It could be
speculated, that the acute release of SOD3 by exocytosis would saturate
the cell surface and hence establish an equilibrium between SOD3 in
the culture supernatant and cell-surface associated protein. However,
ﬂow cytometric analysis shows that the cell surface is not saturated at
30min (Fig. 3), and hence cell surface saturation is likely not the basis
for the observed release. It may also be hypothesized, that the activity
of, e.g. heparanase, would release SOD3 from the cell surface by
cleaving heparan sulfate chains on cell surface proteoglycans; a process
known to release pro-inﬂammatory cytokines including TNFα and IL-1β
[54,55]. Our previous ﬁndings show the level of SOD3 on the macro-
phage cell surface was unaﬀected by LPS stimulation as evaluated after
18 h [37]. Here we show, that within 4 h the level of surface-associated
SOD3 increase and levels oﬀ when evaluated at 6 h (Fig. 3). These
ﬁndings suggest that exocytosis of SOD3-containing vesicles, supports
an initial burst of SOD activity at the cell surface. To what extent this
correlates spatially and temporally with the agonist-regulated traf-
ﬁcking of NADPH oxidase 2 (NOX2)-containing secretory vesicles to the
cell surface is at present unknown [56]. With the active transport of
H2O2 by peroxiporins, it is thus possible that the oxidative burst will
provide elevated levels of H2O2 in the intracellular space to aﬀect the
cellular response, as observed in endothelial cells [20]. Despite the lack
of mechanistic insight, it is clear that the release of SOD3 from the
macrophage could provide a basis for intercellular communication
mediated by SOD activity.
LRP1 is an endocytic receptor and highly expressed by macrophages
[57]. The receptor has the capacity to internalize extracellular ligands
and support intracellular sorting by directing ligands to, e.g., the
lysosomal compartment for degradation or to recycling endosomes for
subsequent release. We show that the uptake of SOD3 into HMDMs is
mediated by the interaction with LRP1. Supported by ﬂow cytometric
analysis of un-stimulated cells, we suggest that SOD3 synthesized in
macrophages is secreted from the cell and immobilized on the cell
surface via the interaction with heparan sulfate proteoglycans (Fig. 8).
This provides a basis for the interaction with LRP1 and allows for in-
ternalization and subsequent sorting into a subcellular compartment
detected by confocal microscopy (Fig. 2) and electron microscopy [39]
(Fig. 8). The identity of this compartment is not yet been established.
However, intracellular SOD3 did not to any appreciable degree colo-
calize with lysosomal markers, and thus SOD3 is probably not con-
tained in LROs, which in macrophages constitute a well known exocytic
compartment. Further analysis will be required to reveal the identity of
the SOD3-containing organelles.
Endocytosis of SOD3 will maintain a steady-state level of SOD3 on
the macrophage cell surface to support redox homeostasis. LPS-stimu-
lation will subsequently mobilize this compartment and allow for the
release of SOD3 into the extracellular space whereby an acute increase
in SOD activity is established (Fig. 8). Since the transcriptional reg-
ulation of SOD3 expression is slow, the stimulus-induced release of a
preformed compartment provides the macrophage with an immediate
redox-modulating factor. Interestingly, NOX2 is contained in a similar
agonist-regulated non-LRO compartment [56]. The assembly of the
NOX2 complex provides a similar acute redox modulating response, by
recruiting cytosolic factors to the membrane-associated gp91phox/
p22phox complex [58].
By using BMMs isolated from wild-type and SOD3−/− mice, we
show that the stimulus-induced release of SOD3 attenuates the secre-
tion of a number of pro-inﬂammatory cytokines, demonstrating that the
release induce a functional impact on macrophage biology (Fig. 7). We
ﬁnd that the level of the chemokines CXCL1 and CXCL2 secreted from
macrophages is increased in the absence of SOD3, although the former
is not statistically signiﬁcant (Fig. 7). This ﬁnding correlates with a
previous study showing that exogenous SOD3 present in culture
medium of an LPS-stimulated macrophage cell line attenuates the level
of secreted CXCL2 [11]. Since CXCL1 and CXCL2 are chemokines cen-
tral to neutrophil traﬃcking [59], these data support the ﬁndings of
Fig. 8. Schematic showing the cellular cycle of SOD3 in macrophages. The
secreted protein binds to glycosaminoglycans on the cell surface and is inter-
nalized via the interaction with LRP1 (1). The internalized SOD3 is sorted and
stored in intracellular vesicles of unknown identity (2). Upon stimulation, the
macrophage has the capacity to mobilize SOD3 from these vesicles to allow for
an acute increase at the cell surface as well as in the surrounding tissue (3). The
concomitant expression of NOX2 activity supports the generation of superoxide
(O2.-) (4). The increased SOD3 activity in the extracellular space has the ca-
pacity to modulate the redox environment and aﬀect endocrine and paracrine
redox-dependent signaling by generating H2O2 as a secondary messenger (5).
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several in vivomodels of inﬂammation presenting an augmented level of
neutrophil recruitment in SOD3−/− animals [3,10,16,60]. Ad-
ditionally, the level of sICAM-1 released from macrophages was also
found to increase in the absence of SOD3. This association has pre-
viously been observed in patients presenting active rheumatoid ar-
thritis, establishing that the level of sICAM in serum correlates nega-
tively with the level of SOD3 [61]. Interestingly, the level of TNFα and
CXCL2 released from rat alveolar macrophages was found to increase
when cells were stimulated with sICAM [62]. The ﬁnding that SOD3−/
− macrophages release relative higher levels of sICAM therefore sub-
stantiates the augmented levels of both TNFα and CXCL2 secreted from
these cells. Conclusively, the modulated cytokine proﬁle shows that the
induced secretion of SOD3 from an intracellular compartment will af-
fect the biological response of the macrophage, and therefore validates
the notion, that SOD3 has the capacity to aﬀect redox-regulated events.
We show that the level of SOD3 in the extracellular space is regu-
lated by cellular uptake and release in macrophages. The induced re-
lease allows the macrophage to acutely modulate the redox conditions
in the extracellular space and suggests that SOD3 plays an important
role in the early phase of macrophage activation and the inﬂammatory
response. Further studies are warranted to describe mechanisms in-
volved in intracellular storage and release of SOD3. Our study adds to
the current knowledge suggesting that SOD3 must be considered as an
active player during the inﬂammatory response.
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Abbreviations
BMM Bone marrow-derived macrophage
CTB Cholera toxin B-subunit
ECM Extracellular matrix
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sICAM1 Soluble intercellular adhesion molecule 1
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